Welcome to our dedicated page for CYABRA news (Ticker: CYAB), a resource for investors and traders seeking the latest updates and insights on CYABRA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CYABRA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CYABRA's position in the market.
Cyabra (Nasdaq: CYAB) announced a yearly six-figure agreement on March 31, 2026 to provide real-time narrative intelligence and evidence-based protection for a major Fortune 500 consumer brand.
Services include narrative and authenticity analysis, proactive alerts, mitigation support, and executive impersonation and fraud risk monitoring. This is Cyabra’s first major customer announcement as a publicly traded company and signals rising enterprise demand for narrative-integrity infrastructure.
Cyabra (Nasdaq: CYAB) closed its business combination with Trailblazer Merger Corp., effective March 27, 2026, and will begin trading on Nasdaq under the ticker CYAB on March 27, 2026.
The combined company will operate as Cyabra, Inc., led by Co‑Founder and CEO Dan Brahmy, with Trailblazer stock and rights formerly trading as TMBC and TMBCR no longer listed.